Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Q Therapeutics, Inc. ([NONE]) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Q Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1366541.
Total stock buying since 2014: $0.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $4,867.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 0 | $0 | 0 | $0 | 32,451 | $4,867 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-07 | 0 | $0 | 0 | $0 | 32,451 | $4,867 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-07-14 | Hutt Peter Barton (Director) | Option Ex | 32,451 | .15 | 4,867 |
Insider trading activities including stock purchases, stock sales, and option exercises of [NONE] listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Q Therapeutics, Inc. (symbol [NONE], CIK number 1366541) see the Securities and Exchange Commission (SEC) website.